Mesoblast (MSB) is held by 17 ASX ETFs as of 20 Nov 2026. It weighs most in ISO, at 0.8% of the fund. Over the last 3 months it fell 28.2%: on $10,000, −$2818. We explain 3 big moves in that time.
About MSB
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$2.2b
- Held by17 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +23.4%peak +26.6%29 Oct 2026· Operational
Mesoblast released a market-sensitive quarterly activities and cash flow report that appears to have contained positive news, driving the stock up over 20%.
- −11.1%peak −11.8%19 Oct 2026· Earnings Miss
Mesoblast fell sharply after releasing quarterly results showing Ryoncil revenue growth that disappointed investors relative to expectations, triggering a 'sell the news' reaction despite headline growth figures.
- +2.6%peak −10.6%16 Oct 2026· Macro
A sharp sell-off in the Nikkei 225 (-4.9%) likely triggered risk-off selling in MSB, a biotech with significant Japanese market exposure, dragging the stock down well beyond the broader ASX move.
Held by 17 ETFs
Of every $10,000 in each fund, how much is in MSB today.
- ISOiShares S&P/ASX Small Ordinaries ETF$770.77%
- SSOSTATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$760.76%
- FAIRBetaShares Australian Sustainability Leaders ETF$490.49%
- VSOVanguard MSCI Australian Small Companies Index ETF$310.31%
- OZXXGlobal X Australia ex Financials & Resources ETF$300.30%
- EX20BetaShares Australian Ex-20 Portfolio Diversifier ETF$210.21%
- GEARBetaShares Geared Australian Equities Complex ETF$170.17%
- VETHVanguard Ethically Conscious Australian Shares ETF$9.490.09%
- STWSTATE STREET SPDR S&P/ASX 200 ETF$8.280.08%
- AYLDGlobal X S&P/ASX 200 Covered Call Complex ETF$8.200.08%
Other Health Care companies
- SHLSonic Healthcare56 ETFs
- RMDResMed49 ETFs
- CSLCSL Limited47 ETFs
- BDXBcal43 ETFs
- CSXCleanspace38 ETFs
- SIGSigma Healthcare37 ETFs
- TLXTelix Pharma37 ETFs
- REGRegis Health36 ETFs